Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Singer

Showing results (181-190 of 253) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Gleason score 6 adenocarcinoma: should it be labeled as cancer?H Ballentine Carter, Alan W Partin, Patrick C Walsh, et al.
Urologic Oncology|May 28, 2023
Annual trends of cystectomy complications: A contemporary analysis of the NSQIP databaseKevin J Chua, Hiren V Patel, Arnav Srivastava, et al.
Urology|March 8, 2013
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillanceYun-Sok Ha, Amirali Salmasi, Michael Karellas, et al.
Oncotarget|January 10, 2018
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkersIzak Faiena, Sinae Kim, Nicholas Farber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2017
Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical OpinionKatherine S Virgo, Ethan Basch, D Andrew Loblaw, et al.
Nature Communications|February 1, 2024
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043Yousef Zakharia, Eric A Singer, Satwik Acharyya, et al.
Urologic Oncology|July 27, 2015
Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United StatesChristopher B Allard, Francisco Gelpi-Hammerschmidt, Lauren C Harshman, et al.
Urology|June 14, 2014
Prostate-specific antigen density toward a better cutoff to identify better candidates for active surveillanceYun-Sok Ha, Jihyeong Yu, Amirali Hassanzadeh Salmasi, et al.
American Journal of Surgery|May 7, 2026
Understanding what surgical advance practice providers want: A survey of autonomy, tasks, and training preferences across three institutionsCharlotte L Harrington, Max J Hyman, Nathan J Graham, et al.
The Journal of Urology|October 25, 2021
Quantifying Publication Rates and Time to Publication for American Urological Association Podium PresentationsKevin J Chua, Mark Mikhail, Hiren V Patel, et al.
Pageof 26

Showing results (181-190 of 253) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Gleason score 6 adenocarcinoma: should it be labeled as cancer?H Ballentine Carter, Alan W Partin, Patrick C Walsh, et al.
Urologic Oncology|May 28, 2023
Annual trends of cystectomy complications: A contemporary analysis of the NSQIP databaseKevin J Chua, Hiren V Patel, Arnav Srivastava, et al.
Urology|March 8, 2013
Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillanceYun-Sok Ha, Amirali Salmasi, Michael Karellas, et al.
Oncotarget|January 10, 2018
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkersIzak Faiena, Sinae Kim, Nicholas Farber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2017
Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical OpinionKatherine S Virgo, Ethan Basch, D Andrew Loblaw, et al.
Nature Communications|February 1, 2024
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043Yousef Zakharia, Eric A Singer, Satwik Acharyya, et al.
Urologic Oncology|July 27, 2015
Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United StatesChristopher B Allard, Francisco Gelpi-Hammerschmidt, Lauren C Harshman, et al.
Urology|June 14, 2014
Prostate-specific antigen density toward a better cutoff to identify better candidates for active surveillanceYun-Sok Ha, Jihyeong Yu, Amirali Hassanzadeh Salmasi, et al.
American Journal of Surgery|May 7, 2026
Understanding what surgical advance practice providers want: A survey of autonomy, tasks, and training preferences across three institutionsCharlotte L Harrington, Max J Hyman, Nathan J Graham, et al.
The Journal of Urology|October 25, 2021
Quantifying Publication Rates and Time to Publication for American Urological Association Podium PresentationsKevin J Chua, Mark Mikhail, Hiren V Patel, et al.
Pageof 26